Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06480240 |
| Title | A Phase 1/2 Study of OBI-992 in Subjects With Advanced Solid Tumors |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | OBI Pharma, Inc |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| California Clinical Trials Medical Group (CCTMG) | Glendale | California | 91206 | United States | Details | |
| Scripps Green Hospital | La Jolla | California | 92037 | United States | Details | |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| NEXT Oncology | San Antonio | Texas | 78229 | United States | Details | |
| NEXT Virginia | Fairfax | Virginia | 22031 | United States | Details | |
| Taipei Tzu Chi Hospital | New Taipei City | Xindian District | 231036 | Taiwan | Details | |
| Taipei Medical University - Shuang Ho Hospital | New Taipei City | Zhonghe District | 23561 | Taiwan | Details |